Health

Lilly’s Zepbound Outage Deepens as Almost All Doses Short

Only lowest dose of weight-loss drug is available, FDA says
Patients across the US have said they can’t get doses

Only the lowest dose of Zepbound, which patients usually use only short-term, is listed as “available,” according to a US Food and Drug Administration database. — Only the lowest dose of Zepbound, which patients usually use only short-term, is listed as “available,” according to a US Food and Drug Administration database.
Photographer: Shelby Knowles/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Madison Muller

April 17, 2024 at 2:17 PM UTC

Updated on

April 17, 2024 at 4:01 PM UTC

This article is for subscribers only.

Nearly all doses of Eli Lilly & Co.’s weight-loss drug Zepbound will now be in shortage through at least the beginning of summer as demand for the blockbuster injections continues to surge.

Only the lowest dose of Zepbound, a 2.5 milligram shot normally used for the first month of treatment, is listed as “available” through the first half of the year, according to the US Food and Drug Administration website. The agency had earlier said just two of six doses would be in limited supply through the end of April.